Second Opinions

The lack of data and transparency should raise questions

A new study reveals the depth of industry influence

Alternative approaches are key following the SCOTUS ruling on race-based admissions

These tools can make us better physicians

The old days of drug nomenclature were simpler

Funding health communication research can empower the public to make informed decisions

Moral considerations must inform clear policy

Here's how to reduce your risk of medical malpractice

They were never intended to be prescriptive

Some of the wrath toward CMGs may be misdirected

Mergers and acquisitions are not a recipe for success in our field

It's the initial outbreak that tells us what we need to know

Provider access is a major challenge for Medicaid patients